Handelsbanken Fonder’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-107,541
| Closed | -$1.55M | – | 1515 |
|
|
2026
Q1 | $1.55M | Hold |
107,541
| – | – | 0.01% | 841 |
|
|
2025
Q4 | $1.53M | Buy |
107,541
+20,100
| +23% | +$197K | ﹤0.01% | 856 |
|
|
2025
Q3 | $689K | Hold |
87,441
| – | – | ﹤0.01% | 1163 |
|
|
2025
Q2 | $501K | Hold |
87,441
| – | – | ﹤0.01% | 1248 |
|
|
2025
Q1 | $714K | Hold |
87,441
| – | – | ﹤0.01% | 1088 |
|
|
2024
Q4 | $824K | Hold |
87,441
| – | – | ﹤0.01% | 1054 |
|
|
2024
Q3 | $934K | Buy |
87,441
+11,500
| +15% | +$125K | ﹤0.01% | 978 |
|
|
2024
Q2 | $753K | Buy |
75,941
+21,900
| +41% | +$225K | ﹤0.01% | 966 |
|
|
2024
Q1 | $637K | Hold |
54,041
| – | – | ﹤0.01% | 1047 |
|
|
2023
Q4 | $767K | Buy |
54,041
+6,200
| +13% | +$70.4K | ﹤0.01% | 923 |
|
|
2023
Q3 | $582K | Buy |
47,841
+2,500
| +6% | +$32.3K | ﹤0.01% | 983 |
|
|
2023
Q2 | $569K | Buy |
45,341
+9,200
| +25% | +$109K | ﹤0.01% | 999 |
|
|
2023
Q1 | $401K | Hold |
36,141
| – | – | ﹤0.01% | 1114 |
|
|
2022
Q4 | $441K | Buy |
36,141
+6,300
| +21% | +$70.9K | ﹤0.01% | 1028 |
|
|
2022
Q3 | $312K | Sell |
29,841
-18,200
| -38% | -$203K | ﹤0.01% | 1234 |
|
|
2022
Q2 | $516K | Sell |
48,041
-1,200
| -2% | -$9.88K | ﹤0.01% | 1005 |
|
|
2022
Q1 | $466K | Hold |
49,241
| – | – | ﹤0.01% | 1256 |
|
|
2021
Q4 | $569K | Hold |
49,241
| – | – | ﹤0.01% | 1262 |
|
|
2021
Q3 | $470K | Hold |
49,241
| – | – | ﹤0.01% | 1393 |
|
|
2021
Q2 | $475K | Hold |
49,241
| – | – | ﹤0.01% | 1421 |
|
|
2021
Q1 | $487K | Hold |
49,241
| – | – | ﹤0.01% | 1213 |
|
|
2020
Q4 | $1.14M | Hold |
49,241
| – | – | 0.01% | 769 |
|
|
2020
Q3 | $695K | Hold |
49,241
| – | – | 0.01% | 838 |
|
|
2020
Q2 | $743K | Buy |
+49,241
| New | +$600K | 0.01% | 794 |
|
Other funds holding FOLD
Handelsbanken Fonder's FOLD Position: Q2 2026 in Review
Handelsbanken Fonder sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 107,541 shares — an estimated $1.55M sold.
Handelsbanken Fonder first reported a position in FOLD in Q2 2020 and held it in 24 quarters. The position peaked at $1.55M in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.
- Handelsbanken Fonder reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- Handelsbanken Fonder sold 107,541 Amicus Therapeutics shares in Q2 2026, an estimated $1.55M.
- Handelsbanken Fonder first reported a position in Amicus Therapeutics in Q2 2020 and held it in 24 quarters.
- Handelsbanken Fonder's Amicus Therapeutics position peaked at $1.55M in Q1 2026.
- 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.